Prolonged Lamivudine treatment in patients with chroni active anti-Hbe positive hepatitis

被引：0
|
作者：
Fazio, V
Angarano, G
Scotto, G
机构：
来源：
JOURNAL OF HEPATOLOGY | 2002年 / 36卷
关键词：
D O I：
10.1016/S0168-8278(02)80457-3
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
457
引用
收藏
页码：128 / 128
页数：1
相关论文
共 50 条
  • [21] ` Evaluation of the need for treatment on 72 subjects with anti-HBe positive chronic hepatitis B
    Amiri, Shima Soleimani
    Shafaee, Shariar
    Roushan, Mohammad Reza Hasanjani
    Baiani, Masomeh
    Hajiahmadi, Mahmoud
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2012, 3 (04) : 519 - 522
  • [22] Is there any correlation between HBV genomic factors and response to lamivudine therapy in anti-HBe positive patients?.
    Buti, M
    Costa, X
    Cotrina, M
    Valdés, A
    Rodriguez, F
    Jardí, R
    Esteban, R
    Guardia, J
    HEPATOLOGY, 2001, 34 (04) : 625A - 625A
  • [23] Reversion from precore mutation to wild type in anti-HBe positive patients on lamivudine therapy.
    Maria, B
    Francisco, RF
    Rosendo, J
    Montse, C
    Rafael, E
    Jaume, G
    HEPATOLOGY, 1999, 30 (04) : 344A - 344A
  • [24] The natural history of Hbe Ag positive and anti-HBe positive chronic hepatitis B patients: A long term study.
    Lee, YM
    GASTROENTEROLOGY, 2002, 122 (04) : A305 - A305
  • [25] High risk of hepatocellular carcinoma in anti-HBe positive liver cirrhosis patients developing lamivudine resistance
    Andreone, P
    Gramenzi, A
    Cursaro, C
    Biselli, M
    Cammà, C
    Trevisani, F
    Bernardi, M
    JOURNAL OF VIRAL HEPATITIS, 2004, 11 (05) : 439 - 442
  • [26] Long term lamivudine in patients with anti-HBE/HBV-DNA positive liver disease.
    Di Marco, V
    Lampertico, P
    Marzano, A
    Andreone, P
    Santantonio, T
    Almasio, PL
    Rizzetto, M
    Craxi, A
    HEPATOLOGY, 2002, 36 (04) : 372A - 372A
  • [27] The effect of lamivudine in Korean patients with anti-HBE/HBV DNA-positive chronic hepatitis B treated for 6 months.
    Choi, KW
    Kim, TN
    Lee, HJ
    HEPATOLOGY, 2000, 32 (04) : 588A - 588A
  • [28] INFLUENCE OF HEPATITIS DELTA-VIRUS INFECTION ON PROGRESSION TO CIRRHOSIS OF ANTI-HBE POSITIVE CHRONIC ACTIVE HEPATITIS
    FATTOVICH, G
    BROLLO, L
    BOSCARO, S
    NOVENTA, F
    STENICO, D
    ALBERTI, A
    REALDI, G
    JOURNAL OF HEPATOLOGY, 1987, 5 : S24 - S24
  • [29] Three years of lamivudine in anti-HBe positive patienits decreased virological and biochemical response
    Ruiz, L
    Valdes, A
    Cotrina, M
    Jardi, R
    Rodriguez-Frias, F
    Costa, X
    Esteban, R
    Guardia, J
    Buti, M
    JOURNAL OF HEPATOLOGY, 2002, 36 : 101 - 102
  • [30] A HBV VARIANT IS RESPONSIBLE FOR ANTI-HBE POSITIVE HEPATITIS-B
    BRUNETTO, MR
    STEMLER, M
    WILL, H
    SCHODEL, F
    OTTOBRELLI, A
    RIZZETTO, M
    VERME, G
    BONINO, F
    HEPATOLOGY, 1989, 10 (04) : 583 - 583
12345